207 results
Page 4 of 11
S-8
EX-23.1
12z9v h9oyn6h2i84
9 Aug 21
Registration of securities for employees
5:28pm
8-K
EX-99.1
4wg73u5dq519kw8gscj
9 Aug 21
FibroGen Reports Second Quarter 2021 Financial Results
4:05pm
8-K
EX-99.1
273348jch5 prf
25 Jun 21
Astellas Receives Positive CHMP Opinion for EVRENZOTM (roxadustat) for Adult Patients with Symptomatic Anemia of Chronic Kidney Disease
5:26pm
8-K
1hip0v7etcb5u15e4
27 May 21
Submission of Matters to a Vote of Security Holders
4:09pm
8-K
EX-99.1
jf9mph2 go
10 May 21
FibroGen Reports First Quarter 2021 Financial Results
4:07pm
8-K
EX-99.1
r58d3gl t2fcjs3j
7 Apr 21
Regulation FD Disclosure
8:30am
8-K
EX-99.1
pvelbpi8
6 Apr 21
Company Continues to be Confident in the Benefit / Risk Profile of Roxadustat
4:59pm
8-K
EX-99.1
y7744
1 Mar 21
FibroGen Reports Fourth Quarter and Full Year 2020 Financial Results
4:06pm
8-K
p8szpu d997q4jmvzpe
27 Jan 21
Entry into a Material Definitive Agreement
12:00am
8-K
EX-99.1
2uueg cqoc9qt3l
18 Dec 20
FibroGen Provides Regulatory Update on Roxadustat
5:10pm